$MODDJun 26, 2026, 1:47 PMAI processed
MODD begins shipping Pivot tubeless insulin patch pump starter kits to endocrinology practices
AI Summary
Modular Medical (MODD) said Pivot tubeless insulin patch pump starter kits are now shipping to endocrinology offices for clinician training, and pumps will be offered to patients in the coming days and weeks. The company plans a phased commercial rollout targeting select high-volume endocrinology practices and metro markets by late 2026, aiming at adults on multiple daily injections (about 70% of insulin-dependent adults) — a large market opportunity but dependent on patient conversion and manufacturing scale.
Positives
- Starter kits are actively shipping to physician offices for clinician training
- Company has a staged commercial rollout plan targeting high-volume endocrinology practices and metro markets by late 2026
- Product targets adults on multiple daily injections (~70% of insulin-dependent adults), representing a large market opportunity
Negatives
- Current shipments are for training; pumps are not yet widely in patient use
- Commercial success depends on patient conversion and the company’s ability to scale manufacturing
- Rollout is phased with a timeline stretching into late 2026, implying a gradual revenue ramp